126 related articles for article (PubMed ID: 20630481)
1. Analysis of the vascular profile and CD99 protein expression in the partial and complete hydatidiform moles using quantitative CD34 immunohistochemistry.
Hussein MR
Exp Mol Pathol; 2010 Dec; 89(3):343-50. PubMed ID: 20630481
[TBL] [Abstract][Full Text] [Related]
2. Vasculogenesis in complete and partial hydatidiform mole pregnancies studied with CD34 immunohistochemistry.
Lisman BA; Boer K; Bleker OP; van Wely M; Exalto N
Hum Reprod; 2005 Aug; 20(8):2334-9. PubMed ID: 15878926
[TBL] [Abstract][Full Text] [Related]
3. Numerous vessels detected by CD34 in the villous stroma of complete hydatidiform moles.
Qiao S; Nagasaka T; Nakashima N
Int J Gynecol Pathol; 1997 Jul; 16(3):233-8. PubMed ID: 9421088
[TBL] [Abstract][Full Text] [Related]
4. Elucidation of vascular structure of molar villi in complete hydatidiform mole by CD-34 antibody.
Yoshida K; Nagasaka T; Nakashima N; Nishida Y; Saito M; Tomomitsu O
Int J Gynecol Pathol; 2000 Jul; 19(3):212-8. PubMed ID: 10907168
[TBL] [Abstract][Full Text] [Related]
5. The villous stromal constituents of complete hydatidiform mole differ histologically in very early pregnancy from the normally developing placenta.
Kim KR; Park BH; Hong YO; Kwon HC; Robboy SJ
Am J Surg Pathol; 2009 Feb; 33(2):176-85. PubMed ID: 18936691
[TBL] [Abstract][Full Text] [Related]
6. Analysis of p53, BCL-2 and epidermal growth factor receptor protein expression in the partial and complete hydatidiform moles.
Hussein MR
Exp Mol Pathol; 2009 Aug; 87(1):63-9. PubMed ID: 19348791
[TBL] [Abstract][Full Text] [Related]
7. Characterization of androgenetic/biparental mosaic/chimeric conceptions, including those with a molar component: morphology, p57 immnohistochemistry, molecular genotyping, and risk of persistent gestational trophoblastic disease.
Lewis GH; DeScipio C; Murphy KM; Haley L; Beierl K; Mosier S; Tandy S; Cohen DS; Lytwyn A; Elit L; Vang R; Ronnett BM
Int J Gynecol Pathol; 2013 Mar; 32(2):199-214. PubMed ID: 23370656
[TBL] [Abstract][Full Text] [Related]
8. What is the optimal duration of human chorionic gonadotrophin surveillance following evacuation of a molar pregnancy? A retrospective analysis on over 20,000 consecutive patients.
Coyle C; Short D; Jackson L; Sebire NJ; Kaur B; Harvey R; Savage PM; Seckl MJ
Gynecol Oncol; 2018 Feb; 148(2):254-257. PubMed ID: 29229282
[TBL] [Abstract][Full Text] [Related]
9. Complete hydatidiform mole with retained maternal chromosomes 6 and 11.
McConnell TG; Norris-Kirby A; Hagenkord JM; Ronnett BM; Murphy KM
Am J Surg Pathol; 2009 Sep; 33(9):1409-15. PubMed ID: 19542869
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and pathogenetic significance of increased stromal apoptosis and incomplete vasculogenesis in complete hydatidiform moles in very early pregnancy periods.
Kim MJ; Kim KR; Ro JY; Lage JM; Lee HI
Am J Surg Pathol; 2006 Mar; 30(3):362-9. PubMed ID: 16538057
[TBL] [Abstract][Full Text] [Related]
11. [Epidemiologic and clinicopathologic studies of partial hydatidiform mole].
Kodama A; Kanazawa K; Honma S; Aoki Y; Tanaka K; Takahashi H
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Sep; 43(9):1219-25. PubMed ID: 1919183
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and outcome of hydatidiform moles in missed-miscarriage: a cohort-study, systematic review and meta-analysis.
Memtsa M; Johns J; Jurkovic D; Ross JA; Sebire NJ; Jauniaux E
Eur J Obstet Gynecol Reprod Biol; 2020 Oct; 253():206-212. PubMed ID: 32877774
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analysis of c-erbB-2, Bcl-2, p53, p21
Missaoui N; Landolsi H; Mestiri S; Essakly A; Abdessayed N; Hmissa S; Mokni M; Yacoubi MT
Pathol Res Pract; 2019 Mar; 215(3):446-452. PubMed ID: 30558966
[TBL] [Abstract][Full Text] [Related]
14. p57kip2 is useful in the classification and differential diagnosis of complete and partial hydatidiform moles.
Jun SY; Ro JY; Kim KR
Histopathology; 2003 Jul; 43(1):17-25. PubMed ID: 12823708
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of BCL-2 in hydatidiform moles: a tissue microarray study.
Al-Jabri M; Al-Badi S; Al-Kindi H; Arafa M
Pathologica; 2023 May; 1(1):148-154. PubMed ID: 37216303
[TBL] [Abstract][Full Text] [Related]
16. Decidual immune cell infiltrate in hydatidiform mole.
Hussein MR; Abd-Elwahed AR; Abodeif ES; Abdulwahed SR
Cancer Invest; 2009 Jan; 27(1):60-6. PubMed ID: 19160109
[TBL] [Abstract][Full Text] [Related]
17. Expression of vascular endothelial growth factor (VEGF), hypoxia inducible factor 1 alpha (HIF-1alpha), and transforming growth factors beta1 (TGFbeta1) and beta3 (TGFbeta3) in gestational trophoblastic disease.
Bolat F; Haberal N; Tunali N; Aslan E; Bal N; Tuncer I
Pathol Res Pract; 2010 Jan; 206(1):19-23. PubMed ID: 19836147
[TBL] [Abstract][Full Text] [Related]
18. Challenges in the Routine Praxis Diagnosis of Hydatidiform Mole: a Tertiary Health Center Experience.
Lelic M; Fatusic Z; Iljazovic E; Ramic S; Markovic S; Alicelebic S
Med Arch; 2017 Aug; 71(4):256-260. PubMed ID: 28974845
[TBL] [Abstract][Full Text] [Related]
19. p57 in Hydatidiform Moles: Evaluation of Antibodies and Expression in Various Cell Types.
Lund H; Nielsen S; Grove A; Vyberg M; Sunde L
Appl Immunohistochem Mol Morphol; 2020 Oct; 28(9):694-701. PubMed ID: 31567274
[TBL] [Abstract][Full Text] [Related]
20. Expression of maspin in gestational trophoblastic disease.
Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF
Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
